AstraZeneca Research Program Technology definition
AstraZeneca Research Program Technology means any Technology made, developed or conceived by employees or consultants of AstraZeneca, alone or jointly with Third Parties, in the conduct of the AstraZeneca Research Activities, but in each case only if not AstraZeneca Assigned Technology. For purposes of clarity, Technology with respect to Ispronicline made, developed or conceived by employees or consultants of AstraZeneca, alone or jointly with Third Parties, shall not be AstraZeneca Research Program Technology.
AstraZeneca Research Program Technology means any Technology made, developed or conceived by employees or consultants of AstraZeneca, alone or jointly with Third Parties, in the conduct of the AstraZeneca Research Activities, but in each case only if not AstraZeneca Assigned Technology. For purposes of clarity, Technology with respect to
AstraZeneca Research Program Technology means any Technology made, developed or conceived by employees or consultants of AstraZeneca, alone or jointly with Third Parties, in the conduct of: (a) the AstraZeneca Research Activities, but in each case only if not AstraZeneca Assigned Technology; or (b) any Clinical Trial of a Basket Compound conducted in whole or in part after the Amendment No. 5 Date, but, solely in the case this clause (b), where such Technology constitutes a method of use or treatment (or otherwise constitutes a new therapeutic use), or pharmaceutical composition, of or for such Basket Compound. For purposes of clarity, (i) Technology with respect to Ispronicline made, developed or conceived by employees or consultants of AstraZeneca, alone or jointly with Third Parties, shall not be AstraZeneca Research Program Technology and (ii) Technology that is AstraZeneca Research Program Technology pursuant to clause (b) above shall also be AstraZeneca Development Program Technology.”
More Definitions of AstraZeneca Research Program Technology
AstraZeneca Research Program Technology means any Technology made, developed or conceived by employees or consultants of AstraZeneca, alone or jointly with Third Parties, in the conduct of: (a) the AstraZeneca Research Activities, but in each case only if not AstraZeneca Assigned Technology; or (b) any Clinical Trial of a Basket Compound conducted in whole or in part after the Amendment No. 5 Date, but, solely in the case this clause (b), where such Technology constitutes a method of use or treatment (or otherwise constitutes a new therapeutic use), or pharmaceutical composition, of or for such Basket Compound. For purposes of clarity, (i) Technology with respect to Ispronicline made, developed or conceived by employees or consultants of AstraZeneca, alone or jointly with Third Parties, shall not be AstraZeneca Research Program Technology and (ii) Technology that is AstraZeneca Research Program Technology pursuant to clause (b) above shall also be AstraZeneca Development Program Technology.”
4. The Agreement is hereby amended by adding the following new Section 1.52A: